Raju Prasad Crispr Therapeutics Ag (CRSP) insider trading activity

CRSP Quotes by TradingView

Raju Prasad is Chief Financial Officer of CRISPR Therapeutics AG. Currently has a direct ownership of 16,767 shares of CRSP, which is worth approximately $657,769. The most recent transaction as insider was on Mar 21, 2025, when has been sold 2,197 shares (Common Shares) at a price of $41.23 per share, resulting in proceeds of $90,582. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.8K
158.91% 3M change
158.91% 12M change
Total Value Held $657,769

Raju Prasad Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 21 2025
SELL
Open market or private sale
$90,582 $41.23 p/Share
2,197 Reduced 11.59%
16,767 Common Shares
Mar 20 2025
BUY
Exercise of conversion of derivative security
-
6,250 Added 24.79%
18,964 Common Shares
Mar 17 2025
SELL
Open market or private sale
$157,251 $41.8 p/Share
3,762 Reduced 22.83%
12,714 Common Shares
Mar 14 2025
BUY
Exercise of conversion of derivative security
-
10,000 Added 37.77%
16,476 Common Shares
Mar 15 2024
SELL
Open market or private sale
$256,159 $72.69 p/Share
3,524 Reduced 35.24%
6,476 Common Shares
Mar 14 2024
BUY
Exercise of conversion of derivative security
-
10,000 Added 50.0%
10,000 Common Shares
RP

Raju Prasad

Chief Financial Officer
Boston, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRSP